API Development_Intas_GB

Intas’ strength is fuelled by early identification of molecules, building a robust API processes and targeting early launch opportunities in key markets through complete backward integration. Intas manufactures APIs covering a wide gamut of therapeutic areas like Oncology, Central Nervous System, Diabetology, Cardiology and more. More than 90% of the APIs manufactured are used for captive consumption.

Intas’ first API manufacturing facility was setup in 2007 with a vision of developing high quality and cost-effective products through indigenous R&D as import substitutes. Today, Intas’ API manufacturing facilities span four different locations and are accredited by stringent global regulatory authorities like USFDA, MHRA, AFFSAPS (France), COFEPRIS (Mexico) and several others, which reinforces its global quality standards. Today, Intas’ APIs are considered to be of global standards and is being used to manufacture finished products to supply highly regulated markets. The company’s current manufacturing capacity is 35 MT/Annum for Oncology APIs and 70 MT/Annum for General APIs.

Watch jobs in this category

Search results for "". Page 1 of 1, Results 1 to 5 of 5
Title Req ID Location Department Date Sort descending
Reset
Qualified Person
Qualified Person GB Quality 10571 16 Jul 2024
10571 GB Quality 16 Jul 2024
Medical Science Liaison
Medical Science Liaison FR Commercial Sales and Marketing 9792 13 Jul 2024
9792 FR Commercial Sales and Marketing 13 Jul 2024
Medical Science Liaison
Medical Science Liaison DE Commercial Sales and Marketing 9829 13 Jul 2024
9829 DE Commercial Sales and Marketing 13 Jul 2024
Regional Key Account Manager - Oncology (Thames Valley and Wessex)
Regional Key Account Manager - Oncology (Thames Valley and Wessex) GB Commercial Sales and Marketing 10717 13 Jul 2024
10717 GB Commercial Sales and Marketing 13 Jul 2024
Executive - QA
Executive - QA IN Quality 11053 11 Jul 2024
11053 IN Quality 11 Jul 2024